Skip to content

Farmadistri: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Farmadistri

BE 0716.742.995
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€479,926
2024 · €408,590+€71,336
Equity
€759,871
2024 · €429,945+€329,926
Cash
€35,359
2024 · €3,587+€31,772
Balance sheet total
€1.6m
2024 · €1.4m+€177,806

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€114,475

    up €114,475 (+8.3%), from €1.4m to €1.5m

  • Cash +€31,772

    up €31,772 (+886%), from €3,587 to €35,359

    mainly Net result for the year (+€479,926) and Current portion of long-term debt (+€11,504)

  • Tangible fixed assets +€23,273

    up €23,273 (+977%), from €2,383 to €25,657

    of which Leasing and similar rights: +€17,567

Equity and liabilities
  • Reserves +€329,926

    up €329,926 (+77.9%), from €423,645 to €753,571

    of which Distributable reserves: +€329,926

  • Other debts -€104,109

    down €104,109 (-26.0%), from €400,000 to €295,891

  • Trade debts -€40,841

    down €40,841 (-8.3%), from €490,828 to €449,988

  • Tax, wage and social debts -€17,840

    down €17,840 (-27.3%), from €65,253 to €47,413

    of which Remuneration and social security: -€11,893

Income statement
  • Gross operating margin +€71,391

    up €71,391 (+11.3%), from €629,847 to €701,238

  • Staff costs -€13,781

    down €13,781 (-12.5%), from €110,439 to €96,658

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €408,590
Gross operating margin +€71,391
Staff costs +€13,781
Depreciation -€1,967
Other operating charges -€362
Financial income -€2,653
Financial charges -€3,910
Taxes -€4,943
Result 2025 €479,926
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€189,795
Investment -€29,917
Financing -€128,106
Cash 2024 €3,587
Net result for the year +€479,926
Depreciation +€7,153
Stocks and contracts -€11,559
Receivables within one year -€114,475
Deferred charges and accrued income +€2,764
Trade debts -€40,841
Tax, wage and social debts -€17,840
Advances received -€36
Other debts -€104,109
Accrued charges and deferred income -€11,189
Investment in fixed assets (net) -€29,917
Debts after one year +€10,390
Current portion of long-term debt +€11,504
Contributions, distributions and other -€150,000
Cash 2025 €35,359
brings cash intakes cash out
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,412,854 €1,590,661 +€177,806 +12.6%
Fixed assets 21/28 €13,185 €35,949 +€22,764 +173%
Intangible fixed assets 21 €10,802 €10,293 -€509 -4.7%
Tangible fixed assets 22/27 €2,383 €25,657 +€23,273 +977%
Plant, machinery and equipment 23 €2,383 €8,089 +€5,706 +239%
Leasing and similar rights 25 - €17,567 +€17,567
Current assets 29/58 €1,399,669 €1,554,711 +€155,042 +11.1%
Stocks and contracts in progress 3 - €11,559 +€11,559
Stocks 30/36 - €11,559 +€11,559
Amounts receivable within one year 40/41 €1,384,158 €1,498,634 +€114,475 +8.3%
Trade receivables 40 €1,384,158 €1,498,634 +€114,475 +8.3%
Cash at bank and in hand 54/58 €3,587 €35,359 +€31,772 +886%
Deferred charges and accrued income 490/1 €11,924 €9,160 -€2,764 -23.2%
Total equity and liabilities 10/49 €1,412,854 €1,590,661 +€177,806 +12.6%
Equity 10/15 €429,945 €759,871 +€329,926 +76.7%
Contributions 10/11 €6,300 €6,300 = 0.0%
Reserves 13 €423,645 €753,571 +€329,926 +77.9%
Tax-exempt reserves 132 €84,200 €84,200 = 0.0%
Distributable reserves 133 €339,445 €669,371 +€329,926 +97.2%
Amounts payable 17/49 €982,909 €830,789 -€152,120 -15.5%
Amounts payable after more than one year 17 - €10,390 +€10,390
Financial debts 170/4 - €10,390 +€10,390
Amounts payable within one year 42/48 €971,333 €820,012 -€151,321 -15.6%
Current portion of amounts payable after more than one year 42 €15,216 €26,720 +€11,504 +75.6%
Trade debts 44 €490,828 €449,988 -€40,841 -8.3%
Suppliers 440/4 €490,828 €449,988 -€40,841 -8.3%
Advances received on contracts in progress 46 €36 - -€36
Taxes, remuneration and social security 45 €65,253 €47,413 -€17,840 -27.3%
Taxes 450/3 €48,045 €42,098 -€5,947 -12.4%
Remuneration and social security 454/9 €17,208 €5,315 -€11,893 -69.1%
Other amounts payable 47/48 €400,000 €295,891 -€104,109 -26.0%
Accrued charges and deferred income 492/3 €11,576 €387 -€11,189 -96.7%
Remuneration, social security and pensions 62 €110,439 €96,658 -€13,781 -12.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €5,185 €7,153 +€1,967 +37.9%
Other operating charges 640/8 €810 €1,172 +€362 +44.7%
Gross operating margin 9900 €629,847 €701,238 +€71,391 +11.3%
Operating profit (loss) 9901 €513,413 €596,255 +€82,842 +16.1%
Financial income 75/76B €2,818 €165 -€2,653 -94.1%
Recurring financial income 75 €2,818 €165 -€2,653 -94.1%
Financial charges 65/66B €1,332 €5,243 +€3,910 +294%
Recurring financial charges 65 €1,332 €5,243 +€3,910 +294%
Profit (loss) for the period before taxes 9903 €514,898 €591,177 +€76,279 +14.8%
Income taxes 67/77 €106,308 €111,251 +€4,943 +4.6%
Profit (loss) for the period 9904 €408,590 €479,926 +€71,336 +17.5%
Profit (loss) for the period to be appropriated 9905 €408,590 €479,926 +€71,336 +17.5%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.